A Study to Identify Biomarker Modulation by a Cyclooxygenase-2 (COX-2) Inhibitor in Breast Tissue of Premenopausal Women at High Risk for Estrogen Receptor Negative (ERN) Breast Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 15 Feb 2017 Biomarkers information updated
- 30 May 2007 Status change from in progress to completed
- 27 Sep 2005 New trial record.